OSE Immunotherapeutics SA(FR:OSE)
€1.41-0.11 (-7.17%)
FR:OSE
OSE Immunotherapeutics SA earnings date
€1.41
At close:-0.11 (-7.17%)
Want to see FR:OSE full AI Analyst Report?
OSE Immunotherapeutics SA (OSE) Q2 2022 Earnings Report
18 Followers
FR:OSE Q2 2022 EPS Results
- Actual EPS
- -EUR 0.11
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.64
FR:OSE Q2 2022 Revenue Results
- Actual Revenue
- EUR 16.05M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +78.80%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 09/22/2022
- Time
- During Market Hours
- Conference Call
- Thursday, September 22, 2022
FR:OSE Upcoming Earnings
OSE Immunotherapeutics SA's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
FR:OSE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | ―- | -1.01 | ― | ― |
| Sep 28, 2026 | 2026 (Q2) | ―- | -0.68 | ― | |
| Apr 30, 2026 | 2025 (Q4) | ―-1.01 | -0.9 | -11.76% (-0.11) | |
| Oct 15, 2025 | 2025 (Q2) | ―-0.68 | 2.63 | -125.99% (-3.31) | |
| Mar 26, 2025 | 2024 (Q4) | ―-0.90 | -0.54 | -67.16% (-0.36) | |
| Sep 26, 2024 | 2024 (Q2) | ―2.63 | -0.64 | 510.63% (+3.27) | |
| Mar 27, 2024 | 2023 (Q4) | ―-0.54 | -0.85 | 36.96% (+0.32) | |
| Sep 27, 2023 | 2023 (Q2) | ―-0.64 | -0.11 | -481.82% (-0.53) | |
| Apr 27, 2023 | 2022 (Q4) | ―-0.85 | -0.29 | -194.83% (-0.56) | |
| Sep 22, 2022 | 2022 (Q2) | ―-0.11 | -0.64 | 82.81% (+0.53) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
